| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |